SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

GMP for excipients: new EU rules on raw materials, packaging, tracking

25-Mar-2015 - The European Commission has published guidelines on GMP excipients after a two-year consultation.

AbbVie bucks Puerto Rico departure trend with $30m expansion

25-Mar-2015 - AbbVie is investing $30m (€27m) in contract manufacturing facilities in Puerto Rico and plans to create 100 jobs over the next two years.

Dispatches from DCAT

Message is clear: Europe is in trouble in terms of pharma growth, experts say

17-Mar-2015 - The European pharma market isn’t likely to deliver much growth over the next five years as generic markets commoditize, IMS Health VP Graham Lewis warned participants at the DCAT (Drug, Chemical and Associated Technologies) conference on Monday.

Penn invests in pill tech citing industry demand

11-Mar-2015 - Penn Pharma has added new tablet making technology at its facility in Tredegar, Wales citing drug industry demand for dry granulation manufacturing capacity.

Johnson Matthey builds HPAPI site in Scotland

11-Mar-2015 - API- and catalyst-maker Johnson Matthey has built high containment facilities for potent products at its site in Edinburgh, Scotland.

Sun Pharma goes after opiates with deal to buy GSK’s Aus business

03-Mar-2015 - Indian giant Sun Pharma has bought GSK’s Australian Opiates business.

California bill would require Big Pharma to unveil how drugs are priced

26-Feb-2015 - A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.

FTC requires Novartis to divest two potential cancer drugs to Array as part of GSK deal

24-Feb-2015 - In order to close Novartis’ $16bn purchase of GlaxoSmithKline’s portfolio of cancer treatments , the FTC (Federal Trade Commission) is requiring Novartis to divest all assets related to its potential BRAF and MEK inhibitor drugs to settle anticompetitive charge.

Fresenius Kabi sells cancer compounding biz to NewCo Pharma

17-Feb-2015 - Fresenius Kabi has sold its cancer drug pharmacy network CFL GmbH to NewCo Pharma GmbH five years after spending €42m to buy compounding capacity in Germany.

survey

Ever wanted to buy catalysts on your iPhone? Now you can thanks to Johnson Matthey

16-Feb-2015 - Quick question for chemists: Have you ever wanted to research chemical reactions and buy catalysts on your mobile phone? 

News in brief

London calling: Gilead to expand operations in UK capital

11-Feb-2015 - Gilead Sciences has committed S20m (€18m) to expand its presence in the UK and will double its workforce in the country.

Dispatches from BIO CEO 2015

Pfizer CEO slams US tax code, calls for more industry consolidation

11-Feb-2015 - In a wide-ranging interview that included his take on competition from Google and R&D spending, Pfizer CEO Ian Read offered a number of clues as to where his company is headed.

Pfizer 'comfortable' with Hospira's manufacturing network after quality review

09-Feb-2015 - Pfizer visited three troubled facilities in Hospira’s manufacturing network before entering a $17bn definitive merger agreement, the company says.

UPDATE

Novartis: New cost-saving unit will not target manufacturing network

29-Jan-2015 - Novartis has divested, restructured, or mothballed 24 manufacturing plants since 2010 but says its new NBS cost-saving business will not focus on streamlining and consolidating sites.

Hospira 'committed to quality' as total recall count hits 40 since 2012

27-Jan-2015 - A human hair found in a vial of Sodium Chloride Injection has led to the fortieth recall in three years for Hospira.

Halal and Kosher stamps of approval for pregnancy drug

26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an oral prescription drug in the US.

Teva: More biomanufacturing space needed to tap biologics opportunities

21-Jan-2015 - Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.

Cost, not compliance, behind Clayton closure, says Hospira

19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.  

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

J&J to receive almost €50m in grants to help manufacture Ebola vaccines

19-Jan-2015 - EFPIA has given J&J subsidiary Crucell Holland and partner Bavarian Nordic €47.6m ($54.9m) to accelerate development of an candidate Ebola vaccine.

Fresenius Kabi NY aseptic plant upgraded by USFDA

15-Jan-2015 - A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

US solvent disposal definition will encourage recycling, says SOCMA

14-Jan-2015 - Critical solvents used by the pharmaceutical manufacturers have been excluded from the EPA's final ruling on waste disposal, in a move welcomed by a US industry group.

Micronization getting bigger: Fareva invests in capacity citing increasing demand

13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.

US FDA approves Impax’s Parkinson’s disease treatment following resolved manufacturing issues

12-Jan-2015 - Almost two years since it was first rejected , Impax Pharmaceuticals said late last week that the US FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.

Spotlight

Message is clear: Europe is in trouble in terms of pharma growth, experts say
Dispatches from DCAT

Message is clear: Europe is in trouble in terms of pharma growth, experts say

The European pharma market isn’t likely to deliver much growth over the next five years as generic...

Distributing donated drugs a major challenge says UK neglected diseases group

Distributing donated drugs a major challenge says UK neglected diseases group

More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...

'Black Mamba' or 'OMG': which fake sex pill has the best name?
QUIZ

'Black Mamba' or 'OMG': which (fake) sexual enhancement pill has the best name?

The FDA has tested hundreds of creatively named bogus supplements and found they contain hidden APIs. Take...

123

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...